NASDAQ:LNTH
Lantheus Holdings Stock News
$67.39
+0.85 (+1.28%)
At Close: May 01, 2024
Add These 4 Top-Ranked Liquid Stocks For Healthy Gains
09:48am, Friday, 03'rd Mar 2023
Here are four top-ranked liquid stocks, Goosehead Insurance (GSHD), Lantheus Holdings (LNTH), Perion (PERI) and UWM Holdings (UWMC), which investors can add to their portfolio for strong gains.
Bull of the Day: Lantheus (LNTH)
06:46am, Thursday, 02'nd Mar 2023
Stunning "beat-and-raise" quarter has analysts scrambling to raise estimates and price targets above $110
2 Medical Stocks to Buy Right Now
07:34pm, Wednesday, 01'st Mar 2023
There is always an essential need for healthcare and here are two Zacks Rank #1 (Strong Buy) medical stocks that investors should consider buying right now.
Why Shares of Lantheus Holdings Rose This Week
08:18am, Saturday, 25'th Feb 2023
The company's fourth-quarter and full-year earnings were a pleasant surprise.
Lantheus Holdings, Inc. (LNTH) Q4 2022 Earnings Call Transcript
02:41pm, Thursday, 23'rd Feb 2023
Lantheus Holdings, Inc. (NASDAQ:LNTH ) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ET Company Participants Mark Kinarney - Vice President of Investor Relations Mary Anne Heino - Preside
Lantheus: Wedging Up To Resistance, Testing Key Retracement Levels (Technical Analysis)
06:38am, Thursday, 16'th Feb 2023
Investors allocating on weakness within new-year rally. Stock wedging up to previous resistance marks, testing key retracement levels.
Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern Time
08:00am, Thursday, 09'th Feb 2023
BEDFORD, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday
Lantheus to Present Piflufolastat F 18 Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
08:30am, Wednesday, 08'th Feb 2023
BEDFORD, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and ar
4 Stocks With Solid Net Profit Margin to Boost Portfolio Return
07:32am, Friday, 03'rd Feb 2023
Let's take a look at four top-ranked stocks - Arch Resources (ARCH), International Game Technology (IGT), Old Second Bancorp (OSBC) and Lantheus Holdings (LNTH) - with solid net profit margins.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:33am, Wednesday, 01'st Feb 2023
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:32am, Wednesday, 25'th Jan 2023
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Will Lantheus Holdings (LNTH) Beat Estimates Again in Its Next Earnings Report?
01:33pm, Tuesday, 24'th Jan 2023
Lantheus Holdings (LNTH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How Much Upside is Left in Lantheus Holdings (LNTH)? Wall Street Analysts Think 83.92%
11:17am, Tuesday, 24'th Jan 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 83.9% in Lantheus Holdings (LNTH). While the effectiveness of this highly sought-after metric is questionable,
Down -8.54% in 4 Weeks, Here's Why You Should You Buy the Dip in Lantheus Holdings (LNTH)
11:17am, Friday, 06'th Jan 2023
The heavy selling pressure might have exhausted for Lantheus Holdings (LNTH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street a
Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference
08:30am, Wednesday, 04'th Jan 2023
NORTH BILLERICA, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiothera